Category: Clinical Trials

July 7, 2021

CRISPR technology offers a cutting-edge approach to gene-editing. New clinical findings from Intellia’s Phase 1 trial have demonstrated for the first time that CRISPR can be administered by infusion to target specific cells within the body.

(more…)

First Name*

Last Name*

Email*

Phone

Address

City

Zip Code

I am a* Please Select Patient Caregiver Patient Family/Friend Academic Physician Nurse Pharma ARC Supporter